Aaron Polliack
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 144
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 138
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 31
- Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 37
- Oncology top 1%
- Viral-associated cancers and disorders 30
-
- Acute Lymphoblastic Leukemia research 38
-
- Glycosylation and Glycoproteins Research 22
-
- Monoclonal and Polyclonal Antibodies Research 20
Aaron Polliack
366 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 148
- Genetics 2.2k
- Pathology and Forensic Medicine 2.5k
- Hematology 1.4k
- Immunology 1.9k
- Oncology 1.8k
Countries citing papers authored by Aaron Polliack
This map shows the geographic impact of Aaron Polliack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Polliack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Polliack more than expected).
Fields of papers citing papers by Aaron Polliack
This network shows the impact of papers produced by Aaron Polliack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Polliack. The network helps show where Aaron Polliack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aaron Polliack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 5 | |
| 2 | 2018 | 5 | |
| 3 | 2017 | 3 | |
| 4 | 2017 | 12 | |
| 5 | 2015 | 13 | |
| 6 | 2015 | 7 | |
| 7 | 2013 | 11 | |
| 8 | 2011 | 15 | |
| 9 | 2011 | 4 | |
| 10 | 2010 | 92 | |
| 11 | 2003 | 16 | |
| 12 | 1996 | 80 | |
| 13 | 1995 | 5 | |
| 14 | 1993 | 6 | |
| 15 | A handbook of essential drugs and regimens in hematological oncology | 1991 | 2 |
| 16 | 1991 | 1 | |
| 17 | 1990 | 1 | |
| 18 | 1984 | 4 | |
| 19 | Surface morphology and ultrastructure of isolated hepatic Kupffer and endothelial cells. | 1978 | 3 |
| 20 | 1973 | 256 |
About Aaron Polliack
Aaron Polliack is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 375 papers that have together received 7.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (144 papers), Lymphoma Diagnosis and Treatment (138 papers), Acute Lymphoblastic Leukemia research (38 papers), Immunodeficiency and Autoimmune Disorders (37 papers), Acute Myeloid Leukemia Research (31 papers), Viral-associated cancers and disorders (30 papers), Glycosylation and Glycoproteins Research (22 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). The work is most often cited by research in Genetics (2.2k citations), Pathology and Forensic Medicine (2.5k citations) and Hematology (1.4k citations). Aaron Polliack has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Tamar Tadmor, Étienne de Harven, I.S. Levij, Yaacov Matzner, Nina Lampen, Yossi Cohen, Hannah Ben‐Bassat, Dina Ben‐Yehuda, Andrea Gallamini and Ariel Aviv. Their work appears in journals such as Blood, European Journal Of Haematology, Hematological Oncology, British Journal of Haematology and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.